Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits...

Area of Science:

• Microbiology
• Immunology
• Vaccine Development

Background:

• Staphylococci, including Staphylococcus aureus and Staphylococcus epidermidis, are significant human pathogens.
• Current therapeutic options are limited, and no vaccines are available to prevent staphylococcal infections.

Purpose of the Study:

• To investigate the potential of manganese transport protein C (MntC) as a vaccine candidate against staphylococcal infections.
• To evaluate the protective efficacy of MntC across different staphylococcal species.

Main Methods:

• In vivo analysis of S. aureus MntC expression during infection.
• Active immunization of mice with MntC and assessment of bacterial load in a bacteremia model.
• Development and testing of anti-MntC monoclonal antibodies in an infant rat passive protection model.
• Evaluation of antibody-induced neutrophil respiratory burst activity.

Main Results:

• MntC is expressed early in the infectious cycle of S. aureus.
• Active immunization with MntC significantly reduced bacterial loads of S. aureus and S. epidermidis in mice.
• Anti-MntC monoclonal antibodies demonstrated protective effects in an infant rat model and stimulated neutrophil activity.

Conclusions:

• MntC is a conserved staphylococcal protein and a promising vaccine target.
• MntC-based immunization strategies can confer protection against both S. aureus and S. epidermidis.
• This study presents the first evidence of a protein with potential for broad protection against staphylococcal species.